A number of Congressional panels have held hearings recently on health policy issues, including the following:

• A House Ways and Means Committee hearing on reforming the health care delivery system to encourage better coordination and higher quality care, such as through bundled payments, health information technology, and value-based purchasing.
• House Energy and Commerce hearings on “Institutional Review Boards that Oversee Experimental Human Testing for Profit” (Oversight Subcommittee), “Making Health Care Work for American Families” (Health Subcommittee), and the “Protecting Consumer Access to Generic Drugs Act of 2009,” which would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market (Commerce Subcommittee).
• A House Appropriations Subcommittee on Labor-HHS hearing on “Pathways to Health Reform: Implementing the National Strategy to Reduce Healthcare-Associated Infections.”
• A Senate Health, Education, Labor and Pensions Committee hearing addressing insurance market reform in national health reform.
• A Finance Committee hearing on the “Role of Long-Term Care in Health Reform.”
• A Senate Commerce Committee hearing on deceptive health insurance industry practices.